A 42-year-old woman with bipolar I disorder on olanzapine 15 mg/day for 3 years presents with weight gain (12 kg), fasting glucose 118 mg/dL, and triglycerides 240 mg/dL. Which of the following metabolic/endocrine complications is NOT associated with olanzapine use?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.